Cite
HARVARD Citation
Abdelrahman, I. et al. (2022). Safety and efficacy of botulinum neurotoxin in the treatment of erectile dysfunction refractory to phosphodiesterase inhibitors: Results of a randomized controlled trial. Andrology. pp. 254-261. [Online].